MARKSANS.NS
MARKSANS.NS
INE750C01026
MARKSANS PHARMA LIMITED
Loading chart...

Company Profile

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Related stocks

RUBICON.NS
RUBICON.NS • India
RUBICON RESEARCH LIMITED
1,548.5 INR
2.65B USD
PFIZER.NS
PFIZER.NS • India
PFIZER LTD
3,808.2 INR
1.8B USD 1Y -27.7%
4536.T
4536.T • Japan
SANTEN PHARMACEUTICAL CO
1,684 JPY
3.42B USD 1Y +7.8%
SANOFICONR.NS
SANOFICONR.NS • India
SANOFI CONS HEALTHC IND L
3,581.7 INR
853.55M USD 1Y -24.8%
300357.SZ
300357.SZ • China
WOLWO PHARMA
19.99 CNY
1.57B USD 1Y -30.7%
002019.SZ
002019.SZ • China
YIFAN PHARM
9.66 CNY
1.76B USD 1Y -30.7%
SANOFI.BO
SANOFI.BO • India
SANOFI INDIA LTD
2,945.55 INR
700.95M USD 1Y -37%
300181.SZ
300181.SZ • China
ZUO LI YAO YE
13.25 CNY
1.39B USD 1Y -25.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
45.0% p.a.
Max Drawdown (5Y)
-55.6%
Sharpe Ratio (5Y)
0.71
Beta Factor
1.15
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -81.5% in the extended horizon.
ende